SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : CEPH -- Ignore unavailable to you. Want to Upgrade?

To: Rusty Johnson who wrote (740)5/13/1998 12:37:00 AM
From: Kevin G. O'Neill  Read Replies (1) | Respond to of 998
 
Options? Straddles? I get it but I'm just not suited for it yet, or at least not here. I did know guys like you in High School though, if that helps. <g>

With CEPH the key is, really, does the drug help the patients? If it does, well, then, the company deserves a rich valuation. I find this one difficult to play, tradewise. Best of luck to you either way. -kgo



To: Rusty Johnson who wrote (740)5/13/1998 12:54:00 AM
From: TokyoMex  Read Replies (1) | Respond to of 998
 
The problem is ,,when the stocks pop,, options guys will not let it pop in conjunction with the stock ,, there is some crazy crooked understanding that the stock has trade in that new range for a while for options to catch up ... that's where you get screwed as options are time erosive..


HomeMailHotSubjectMarksPeopleMarksKeepersSettings
Terms Of UseContact UsCopyright/IP PolicyPrivacy PolicyAbout UsFAQAdvertise on SI
© 2025 Knight Sac Media.  Data provided by Twelve Data, Alpha Vantage, and CityFALCON News